A dual-sheath approach in minimally invasive percutaneous nephrolithotomy is associated with reduced residual stone risk: a two-center retrospective study
To compare the efficacy and safety of a novel dual-sheath approach (combined metal and peel-away sheath) versus a single peel-away sheath in minimally invasive percutaneous nephrolithotomy (MIPCNL) for complex renal or ureteral calculi, and to identify factors associated with postoperative residual stones. This retrospective two-center study included 211 patients with complex renal or ureteral calculi who underwent MIPCNL between January 2023 and December 2024 (dual-sheath group, n =123; single-sheath group, n =88). All procedures were performed by experienced surgeons following a standardized protocol. Propensity score matching (PSM) was applied to balance baseline characteristics. Cox proportional hazards models were used to identify factors associated with residual stones. Kaplan–Meier analysis with log-rank testing was used to compare cumulative residual stone risk between groups. Baseline characteristics were generally comparable between groups. The dual-sheath group showed a trend toward a higher 4-week stone-free rate compared with the single-sheath group (82.9% vs. 71.6%, P =0.072). The secondary intervention rate was significantly lower in the dual-sheath group (0.81% vs. 12.5%, P <0.001). No significant differences were observed in postoperative complication rates between groups. Cox regression analysis indicated that dual-sheath use was independently associated with a reduced risk of residual stones (HR =0.47, 95% CI: 0.25–0.88, P =0.019), with consistent results across sensitivity models. Kaplan–Meier analysis demonstrated a significantly lower cumulative incidence of residual stones in the dual-sheath group (log-rank P =0.0063). The dual-sheath technique appears to be a feasible and safe modification of MIPCNL for complex renal or ureteral calculi. It is associated with a reduced risk of residual stones and fewer secondary interventions, while a non-significant trend toward improved stone-free rates was observed. Further prospective multicenter studies are needed to confirm these findings.
Authors
- 李金明
- Yabo Wang (ORCID: https://orcid.org/0000-0001-8925-5277)
- 柯昌兴
- Dengjun Han
- Hui Liu (ORCID: https://orcid.org/0000-0002-3335-3756)
- Pengpeng Wang (ORCID: https://orcid.org/0000-0002-0161-1933)
- Yan Shi (ORCID: https://orcid.org/0000-0001-6140-9748)
- Changyi Jiang (ORCID: https://orcid.org/0000-0002-9094-0009)
- Erli Wang
- Yong Chen
- Qin Li
- Mingzhao Xiao
Institutions
- Sichuan University (CN)
- Kunming Medical University (CN)
- West China Hospital of Sichuan University (CN)
- Suizhou Central Hospital (CN)
- Maternal and Child Health Hospital of Sichuan Province (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Zigong First People's Hospital (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1186/s40001-026-05340-6
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00